Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 25267740

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Nov 1
First author
Crump M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Nov 1;32(31):3472-3. doi: 10.1200/JCO.2014.56.6802.
    note
    Source null
    related pmid
    25267756
    relationship
    Comment in

Authors and identifiers

  1. name
    Crump M
    type
    Author
  2. name
    Kuruvilla J
    type
    Author
  3. name
    Couban S
    type
    Author
  4. name
    MacDonald DA
    type
    Author
  5. name
    Kukreti V
    type
    Author
  6. name
    Kouroukis CT
    type
    Author
  7. name
    Rubinger M
    type
    Author
  8. name
    Buckstein R
    type
    Author
  9. name
    Imrie KR
    type
    Author
  10. name
    Federico M
    type
    Author
  11. name
    Di Renzo N
    type
    Author
  12. name
    Howson-Jan K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Crump M
    type
    Author
  2. name
    Kuruvilla J
    type
    Author
  3. name
    Couban S
    type
    Author
  4. name
    MacDonald DA
    type
    Author
  5. name
    Kukreti V
    type
    Author
  6. name
    Kouroukis CT
    type
    Author
  7. name
    Rubinger M
    type
    Author
  8. name
    Buckstein R
    type
    Author
  9. name
    Imrie KR
    type
    Author
  10. name
    Federico M
    type
    Author
  11. name
    Di Renzo N
    type
    Author
  12. name
    Howson-Jan K
    type
    Author
bibliography ids
  1. nci-bib-053674e24d40e915737d5b3d
book metadata
content sha256
b1cbcf81fc6086d9f805af89e7e397112b4078b4ad3ae9d7c9aefd44544d5fe1
document type
citation
dois
  1. 10.1200/JCO.2013.53.9593
electronic publication date
display
2014 Sep 29
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25267740
immutable id
pubmed:25267740@b1cbcf81fc6086d9f805af89e7e397112b4078b4ad3ae9d7c9aefd44544d5fe1
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
31
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3490-6
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Nov 1;32(31):3472-3. doi: 10.1200/JCO.2014.56.6802.
    note
    Source null
    related pmid
    25267756
    relationship
    Comment in
outcomes validated
false
pmid
25267740
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
9d6c857ab72c1de6a7e6e2f03cbc7ad96e6c54397d992287ce37698989e12272
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Nov 1
precision
day
year
2014
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25267740/
title
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.

Preserved source evidence · Independent clinical review pending · Not medical advice